Sources | Names Used |
---|---|
CTRPv2 | BRD-K26531177 |
PharmacoGx | BRD-K26531177 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VCX | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | RBMY1E | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | RBMY1D | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
mRNA | RBMY1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | VCX3A | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | RBMY1A1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | VCX2 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | MAGEB16 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |